首页 工具
登录
购物车
Plerixafor octahydrochloride

Plerixafor octahydrochloride

产品编号 T1776L   CAS 155148-31-5
别名: 盐酸普乐沙福, JM3100 octahydrochloride, Plerixafor 8HCl (AMD3100 8HCl), Plerixafor 8HCl, SID791 octahydrochloride, AMD 3100 octahydrochloride, JM 3100 8HCl

Plerixafor octahydrochloride (JM3100 octahydrochloride) 是一种选择性的CXCR4拮抗剂,IC50为 44 nM。Plerixafor 是一种具有造血干细胞动员活性的双环霉素。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Plerixafor octahydrochloride Chemical Structure
Plerixafor octahydrochloride, CAS 155148-31-5
规格 价格/CNY 货期 数量
1 mg ¥ 166 现货
5 mg ¥ 335 现货
10 mg ¥ 517 现货
25 mg ¥ 928 现货
50 mg ¥ 1,610 现货
100 mg ¥ 2,690 现货
200 mg ¥ 3,960 现货
500 mg ¥ 6,260 现货
其他形式的 Plerixafor octahydrochloride:
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
重组蛋白限时优惠
产品目录号及名称: Plerixafor octahydrochloride (T1776L)
点击图片重新获取验证码
选择批次  
纯度: 99.96%
纯度: 98.01%
纯度: 97.66%
TargetMol batch loading
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Plerixafor octahydrochloride (JM3100 octahydrochloride) blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. Plerixafor is a bicyclam with hematopoietic stem cell-mobilizing activity.
靶点活性 CXCR4:44 nM, CXCL12:5.7 nM
体外活性 AMD 3100 can inhibit the replication of low-passage clinical HIV-1 isolates (K31, D370, K6/-2, HEM, and JRCSF) in primary T4 lymphocytes (EC50s: 0.16-1.5 ng/ml; EC90s: 0.36-4.7 ng/ml). In primary monocytes, AMD 3100 was active against HIV-1 (K31 and SF-162) at EC50s of 0.28-7.2 ng/mL and EC90s of 0.68-12 ng/mL.
体内活性 Serum drug levels in rabbits given AMD 3100 (10 mg/kg) by the subcutaneous route were determined by a bioassay based on the EC50 of the compound required to inhibit HIV-1 cytopathicity in MT-4 cells.
细胞实验 Plerixafor is dissolved in DMSO and then diluted with appropriate medium[2]. U87 mg cells are seeded in 96-well plates at the density of 6×103 cells in 200 μL/well and treated with CXCL12, Plerixafor or with peptide R, as described in the previous "Treatments" section. MTT (5 μg/mL) is added at each time point (24, 48, 72 h) during the final 2 h of treatment. After removing cell medium, 100 μL DMSO are added and optical densities measured at 595 nm with a LT-4000MS Microplate Reader. Measurements are made in triplicates from three independent experiments[2].
别名 盐酸普乐沙福, JM3100 octahydrochloride, Plerixafor 8HCl (AMD3100 8HCl), Plerixafor 8HCl, SID791 octahydrochloride, AMD 3100 octahydrochloride, JM 3100 8HCl
分子量 794.46
分子式 C28H62Cl8N8
CAS No. 155148-31-5

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: Insoluble

H2O: 119.17 mg/mL (150 mM), Sonication is recommended.

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
H2O 1 mM 1.2587 mL 6.2936 mL 12.5872 mL 31.4679 mL
5 mM 0.2517 mL 1.2587 mL 2.5174 mL 6.2936 mL
10 mM 0.1259 mL 0.6294 mL 1.2587 mL 3.1468 mL
20 mM 0.0629 mL 0.3147 mL 0.6294 mL 1.5734 mL
50 mM 0.0252 mL 0.1259 mL 0.2517 mL 0.6294 mL
100 mM 0.0126 mL 0.0629 mL 0.1259 mL 0.3147 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Zabel BA, et al. J Immunol. 2009, 183(5), 3204-3211. 2. Fricker SP, et al. Biochem Pharmacol. 2006, 72(5), 588-596. 3. Nishimura Y, et al. J Invest Dermatol. 2012, 132(3 Pt 1), 711-720. 4. Kumar S, et al. Bone, 2012, 50(4), 12012-12018. 5. Li Y, Niu M, Zhao A, et al. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease[J]. Journal of Neuroinflammation. 2019, 16(1): 1-14.

TargetMol Library Books文献引用

1. Li Y, Niu M, Zhao A, et al. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease. Journal of Neuroinflammation. 2019, 16(1): 1-14
Prunin Retro-2 Rupintrivir LabMol-319 FGI-106 tetrahydrochloride Lycorine hydrochloride Danthron STING agonist-1

相关化合物库

该产品包含在如下化合物库中:
抑制剂库 抗癌上市药物库 GPCR靶点分子库 抗癌活性化合物库 药物功能重定位化合物库 抗癌临床化合物库 抗癌药物库 膜蛋白靶向化合物库 EMA 上市药物库 自噬库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Plerixafor octahydrochloride 155148-31-5 Autophagy GPCR/G Protein Immunology/Inflammation Microbiology/Virology Proteases/Proteasome Virus Protease HIV Protease CXCR AMD 3100 SID 791 SID-791 JM-3100 Octahydrochloride AMD-3100 Octahydrochloride SID-791 Octahydrochloride JM3100 Octahydrochloride AMD-3100 Plerixafor Octahydrochloride AMD3100 8HCl 盐酸普乐沙福 JM3100 octahydrochloride AMD3100 SID791 HIV CXC chemokine receptors SID 791 Octahydrochloride AMD3100 Octahydrochloride Plerixafor 8HCl (AMD3100 8HCl) AMD3100 octahydrochloride Human immunodeficiency virus inhibit JM 3100 Plerixafor 8HCl SID791 octahydrochloride Inhibitor JM-3100 AMD 3100 Octahydrochloride JM 3100 Octahydrochloride Plerixafor SID791 Octahydrochloride AMD 3100 octahydrochloride JM 3100 8HCl JM3100 inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼